In this seminar paper I want to discuss about IBM’s efforts in the biotechnology and nanotechnology sector. As the lecture international management designated I will coin these efforts with strategies of market entry within Germany. I have chosen IBM, a US-based company, because it is highly involved in building future technologies. The Company is well known for its activities around the world and sees itself as a globally integrated enterprise. However, cultural attitudes of different countries still determine the success or failure of market entries. Germany is known as a technology-leading country. Also dealing with powerful NGO’s the success of new market entry with modern technology might seems less predictable .
In the first part of this paper I give a brief description about IBM, its research fields related to the topic and outline four research examples. Followed by an introduc-tion of Germany’s cultural attitude to bio- and nanotechnology I provide some strategic suggestions on how IBM could manage the expansion of its efforts within the targeted country.
Inhaltsverzeichnis (Table of Contents)
- Introduction
- About IBM Research
- IBM’s efforts in biotechnology
- Nanotechnology & nanoscience
- DNA-sequencing and beyond
- Computational biology research
- Lab-on-a-chip
- Germany’s attitude to bio- and nanotechnology
- Biotechnology
- Nanotechnology
- Conclusion and recommendations for market entry strategies
- Nanotechnology & nanoscience
- DNA-sequencing and beyond
- Computational biology research
- Lab-on-a-chip
Zielsetzung und Themenschwerpunkte (Objectives and Key Themes)
This seminar paper discusses IBM's efforts in the biotechnology and nanotechnology sectors, specifically focusing on market entry strategies within Germany. The paper aims to analyze IBM's research fields and outline four research examples related to the topic. Additionally, it examines Germany's cultural attitude toward bio- and nanotechnology and provides strategic suggestions on how IBM could manage the expansion of its efforts in this country.
- IBM's research in biotechnology and nanotechnology.
- Cultural attitudes toward biotechnology and nanotechnology in Germany.
- Market entry strategies for IBM in Germany.
- Potential risks and opportunities for IBM's research developments in Germany.
- The role of partnerships and government funding in IBM's market entry strategy.
Zusammenfassung der Kapitel (Chapter Summaries)
The introduction provides an overview of IBM's global operations and its significant investments in research. It emphasizes the importance of understanding cultural attitudes in different countries to determine the success of market entries.
The second chapter focuses on IBM Research, highlighting the company's efforts in biotechnology and nanotechnology. It discusses the key research areas within IBM, including nanotechnology & nanoscience, DNA-sequencing, computational biology research, and lab-on-a-chip. The chapter also presents four concrete examples of IBM's research activities in these fields.
The third chapter examines Germany's cultural attitude toward bio- and nanotechnology. It analyzes the country's historical and current perspectives on biotechnology and nanotechnology, highlighting the challenges and opportunities associated with these fields. The chapter also addresses the role of government regulations, public discourse, and stakeholder engagement in shaping Germany's attitude.
The conclusion provides recommendations for market entry strategies for IBM Research developments in Germany. It discusses potential opportunities and risks for each of the four research examples presented in the second chapter. The conclusion also emphasizes the importance of partnerships, government funding, and building trust with German stakeholders.
Schlüsselwörter (Keywords)
This seminar paper explores the intersection of biotechnology, nanotechnology, market entry strategies, and cultural attitudes in Germany. Key terms and concepts include IBM research, bio- and nanotechnology, DNA-sequencing, computational biology, lab-on-a-chip, Germany's cultural attitudes, government regulations, public discourse, partnerships, and stakeholder engagement. The paper analyzes how these elements interact to shape potential market entry strategies for IBM in Germany.
- Quote paper
- Daniel Bartel (Author), 2011, Analysis of the bio- and nano-technological market of Germany to find market entry strategies for chosen IBM Research Developments, Munich, GRIN Verlag, https://www.grin.com/document/166365
